跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方泛影葡胺注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Meglumine Diatrizoate Injection
Approved
化学药品
Compound Meglumine Diatrizoate Injection
金陵药业股份有限公司浙江天峰制药厂
🇨🇳 National Medical Products Administration
Approval Date
Aug 10, 2020
Approval ID
7LeafrsETUb
Company
金陵药业股份有限公司浙江天峰制药厂
Type
化学药品
Approval Details
Approval Id
7LeafrsETUb
Approval Number
国药准字H33022661
Generic Name
复方泛影葡胺注射液
Generic Name En
Compound Meglumine Diatrizoate Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
20ml:12g(内附1ml:0.3g的试验针)
Reg Date
2020-08-10
Company Name
金陵药业股份有限公司浙江天峰制药厂
Company Address
湖州市经济技术开发区大享路518号
Production Company Name
金陵药业股份有限公司浙江天峰制药厂
Production Company Address
湖州市经济技术开发区大享路518号
Company Detail Path
/organization/jin-ling-yao-ye-gu-fen-you-xian-gong-si-zhe-jiang-tian-feng-zhi-yao-han
Production Company Detail Path
/organization/jin-ling-yao-ye-gu-fen-you-xian-gong-si-zhe-jiang-tian-feng-zhi-yao-han
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 10, 2020
Approval ID
7LeafrsETUb
Type
化学药品
Back to NMPA Approvals